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WHAT IS ALREADY KNOWN? 
• In addition to being associated with a number of deleterious health and wellbeing 
outcomes including, type II diabetes mellitus, cancer and cardiovascular disease, 
overweight BMI in midlife confers a 35% increased risk of developing Alzheimer’s 
disease (AD), compared with normal BMI. 
STUDY IMPORTANCE 
• Our findings indicate that the detrimental effects of overweight/obesity on the 
neurological health of individuals may extend beyond the duration of 
overweight/obesity itself.  
• The clinical translation of our research findings is important to ensure that possible 
populations at risk of poor neurological health are not overlooked, and instead, 






   
ABSTRACT 
OBJECTIVES: To investigate the relationship between fat mass i.e. body mass index 
(BMI), waist circumference (WC) and waist-to-hip ratio (WTHR); and changes in fat 
mass over time with hippocampal volumes (HVs). 
METHODS: UK Biobank participants (n = 20395) aged 40-70 (mean follow up = 7.66 
years), were included and categorised into one of four groups, which represented their 
baseline fat mass status and trajectory of change by follow up assessment i.e. normal to 
overweight/obese (NO), overweight/obese to normal (ON), normal stable (NS) or 
overweight/obese stable (OS).  Regression models used NS (i.e. WC: < 80 cm in women 
and < 94 cm in men; WTHR: < 0.85 in women and < 0.90 in men and BMI: < 25 kg/m2 
in women and men), as the reference. HVs were automatically segmented. 
RESULTS: Compared to NS, OS (BMI: B = -62.33, standard error [SE] = 16.76; WC: B 
= -145.68, SE = 16.97 and WTHR: B = -101.44, SE = 19.54) and ON (BMI: B = -61.15, 
SE = 30.3; WC: B = -93.81, SE = 24.96 and WTHR: B = -69.95, SE = 26.22) had 
significantly lower HVs.  
CONCLUSIONS: The detrimental effects of overweight/obesity may extend beyond the 
duration of overweight/obesity itself.  
 
   
INTRODUCTION 
The prevalence of overweight and obesity has accelerated in recent decades, with current 
global estimates indicating that the proportion of adults with a body mass index (BMI) 
greater than 25 kg/m2 (i.e. overweight) is one in three (1, 2). These findings are of 
particular importance within the context of our globally ageing population given that 
previous research has demonstrated that, in addition to being associated with a number of 
unfavourable health and wellbeing outcomes including, type II diabetes mellitus, cancer 
and cardiovascular disease (3), overweight BMI in midlife confers a 35% increased risk 
of developing Alzheimer’s disease (AD), compared with normal BMI (4). These findings 
emphasise the need to investigate the association between overweight/obesity and 
measures of neurological health. 
Whilst the precise mechanism linking overweight and obesity to AD remains unclear, 
neuroimaging studies have indicated that global and central adiposity in middle-aged 
adults is associated with brain atrophy (5, 6), which may be related to the functional 
attenuation of learning and memory networks (7) that are also vulnerable to AD 
pathology (8, 9). Notably, the hippocampus is a brain region which is sensitive to 
changes, particularly in the early stages of neurodegeneration (8-10), such as AD. 
However the association between fat mass and hippocampal volume in middle to early-
old aged adults has been less consistent with studies reporting negative (11-14), positive 
(15)  or no association (16-18). The inconsistent evidence is surprising given that the 
accumulation of fat tissue, particularly visceral fat, which is often prevalent in individuals 
   
with overweight/obesity is known to be closely linked with elevated levels of pro-
inflammatory cytokines (19-21), which have been associated with smaller hippocampal 
volumes (22). The heterogeneous results may be explained by the typical use of BMI, 
which does not precisely index changes in visceral fat and is inherently biased by the 
ageing process (23). Therefore, other cost-effective, feasible and useful clinical measures, 
including waist circumference (WC) and/or waist-to-hip ratio (WTHR) may be better 
suited for representing changes in visceral fat. Critically, objectively measured 
longitudinal changes in WC and WTHR have not been adequately investigated in 
previous studies that have examined the relationship between fat mass and hippocampal 
volume (12, 16, 17, 24). 
The current study aimed to rectify these shortcomings by investigating the associations 
between fat mass (i.e. BMI, WC and WTHR) and changes in fat mass over time with 
hippocampal volumes in middle to early-old aged women and men. Secondary aims were 
to determine (1) whether these associations differed between measures of fat mass (i.e. 
BMI, WC and WTHR) and (2) which measure(s) of fat mass were most strongly 
associated with total body fat and visceral fat as measured by the gold standard tool, dual-
energy x-ray absorptiometry (DEXA). It was hypothesised that any observed associations 
between fat mass and the hippocampus would be dependent on i) baseline fat mass status 
(i.e. normal, overweight or obese), ii) the trajectory of change and iii) the measure of fat 
mass used. It was predicted that individuals who were classified as chronically 
overweight/obese (and thereby experience chronic, low grade systemic inflammation as 
well as other comorbidities), would have lower hippocampal volumes than those who 
   
progressed from normal weight to overweight/obese categories, or maintained their 
weight within the normal range. Furthermore, it was hypothesised that these results 
would be best represented by the fat mass measure which was most suited for indexing 
changes in visceral fat.  
METHODS 
Participants 
A total of 502536 participants aged 37-73 years at baseline (2006 - 2010) were from the 
UK Biobank study (25) and considered for inclusion. Participants were recruited from the 
National Health Service central registers. Of those considered, as a minimum 
requirement, only those who had completed a structural MRI scan (21390) and had a 
measure of BMI, WC and HC at baseline and follow up assessment (2014 +) were 
included (20849). After excluding participants with neurological disorders, including 
stroke (n = 256) or those who were underweight i.e. BMI <18.5 kg/m2 (n = 179), or had 
extreme obesity i.e. BMI > 50 kg/m2  (n = 20), 20395 participants remained for analysis 
in the present study.   
Fat mass measures 
Trained staff used standardised procedures to obtain body size measurements. 
Participants were asked to remove shoes, socks and heavy outer clothing before body 
weight was measured with the Tanita BC-418 MA body composition analyser (Tanita, 
   
Tokyo, Japan) and standing height was measured using a Seca 202 height measure (Seca, 
Hamburg, Germany). BMI was calculated with the formula: weight (kg) / height2 (m2). 
WC was measured with a Wessex non-stretchable sprung tape measure (Wessex, United 
Kingdom) at the level of the umbilicus, while HC was measured at the widest point. 
WTHR was computed (i.e. waist circumference (cm) / hip circumference (cm)). Total 
body fat (TBF) and visceral fat (VF) was measured (for 4482 and 4431 participants 
respectively) using a dual-energy x-ray absorptiometry (DEXA) device, specifically, the 
GE-Lunar iDXA (GE Healthcare, Chicago, Illinois, Unites States of America) 
Of the 20395 participants included in the study, 5080 had an additional follow up 
measure of fat mass (Figure 2). For these participants, annual changes in fat mass was 
calculated with the formula: 
y = B0 + B1follow up (years) 
Where B0 is the fat mass at each timepoint and B1 is the annual change in fat mass. 
For each measure of fat mass, participants were then categorised into one of four groups, 
which represented their baseline fat mass status and their trajectory of change by follow 
up assessment i.e. normal to overweight/obese (NO), overweight/obese to normal (ON), 
normal stable (NS) or overweight/obese stable (OS). Standardised criteria from the 
International Diabetes Federation (26) and the World Health Organization (27, 28) were 
used to classify normal and overweight/obese groups. Specifically, BMI for men and 
women: overweight/obese >= 25 kg/m2, normal < 25 kg/m2; WC for women: 
   
overweight/obese >= 80 cm, normal < 80 cm; WC for men: overweight/obese >= 94 cm, 
normal < 94 cm; WTHR for women: overweight/obese >= 0.85, normal < 0.85 and 
WTHR for men: overweight/obese >= 0.90, normal < 0.90. 
Covariates 
Covariates included sex, follow-up period, self-reported age and educational attainment,  
vascular/heart problems (i.e. heart attack, angina or hypertension) and diabetes, 
diagnosed by doctor. Participants were classified as having hypertension if they were 
using blood pressure medication and also, as having diabetes if they were using 
medication, such as insulin. Further covariates included self-reported physical activity 
(i.e. number of days per week spent doing at least 10 minutes of continuous vigorous 
activity), smoking (i.e. ever or never) and frequency of alcohol intake. 
Structural MRI 
All participants were imaged across three imaging centres with identical scanners (3T 
Siemens Skyra; software platform VD13) using a 32-channel head coil (29). T1-weighted 
images were acquired in the sagittal orientation using a 3D magnetization-prepared rapid 
acquisition gradient echo (MPRAGE) sequence over a duration of 5 minutes; resolution = 
1 x 1 x 1 mm; field of view = 208 x 256 x 256 matrix (29). We used the imaging derived 
phenotypes (IDPs) generated by the UK Biobank brain imaging team, who acquired, 
processed and analysed the imaging data (29,30) using FMRIB Software Library (FSL) 
v6.0 (http://fsl.fmrib.ox.ac.uk/fsl).  Hippocampal volumes were automatically segmented 
   
using FIRST (FMRIB’s Integrated Registration and Segmentation Tool) and normalised 
for head size by multiplying the IDP with the T1-based headsize scaling factor, which 
was estimated when transforming from native to standard space 
(http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1977). 
Statistical methods 
All statistical analyses were conducted using R (version 3.6.1), in RStudio (version 
1.1.419). Pearson’s correlation coefficients were used to measure the strength of the 
associations between BMI, WC, WTHR and DEXA measurements of total body fat 
(TBF) and visceral fat (VF). Multiple linear hierarchical regression models were then 
computed to quantify the association between fat mass and changes in fat mass 
(specifically BMI, WC and WTHR) and hippocampal volumes, while controlling for age 
and sex (Model 1). Model 2 further controlled for education, vascular/heart problems, 
diabetes, physical activity, smoking and alcohol use. Analysis which investigated the 
associations between fat mass categories (i.e. NO, ON, NS and OS) and the hippocampus 
also adjusted for length of follow up (years). Within each fat mass category, longitudinal 
changes in fat mass and the hippocampus were assessed. All analyses were repeated 
separately for the left and right hippocampal volumes. Since the fat mass thresholds for 
categorisation differed between men and women (particularly for WC and WTHR), these 
analyses were repeated separately. Both unstandardised beta-coefficients and annual 
percentage change in fat mass were utilised in the reporting and interpretation of results, 
where appropriate. Annual percentage change was calculated by dividing the annual 
   
change in fat mass by the baseline fat mass, multiplied by 100. The alpha level was set at 
< 0.05. Assumptions of linearity, homoscedasticity and normality of residuals were 
examined.  
RESULTS 
The participants’ demographic and health characteristics are presented in Table 1. 
Differences between those who were included and excluded have been reported in 
Supplementary Table 1. For those included, participants were on average 54.86 years 
(standard deviation [SD] = 7.48) with a mean follow-up of 7.66 years (SD = 1.42) at 
baseline. The average total hippocampal volume was 7709.73mm3, (SD = 867.92mm3). 
On average, participants lost 68.6 grams/year over the follow up period. Boxplots of fat 
mass change over the follow up between NS, NO, OS and ON groups are presented in 
Figure 1. Demographic information for NS, NO, OS and ON groups for each fat mass 
measure are presented in Supplementary Tables 2-4. 
Cross-sectional analyses revealed that after adjusting for all covariates, higher BMI, WC 
and WTHR were each individually associated with lower hippocampal volumes 
(Supplementary Table 5; BMI: B = -9.63, standard error [SE] = 1.77; WC: B = -6.75, SE 
= 0.69 and WTHR: B = -691.97, SE = 119.12). These results were consistently observed 
for the left and right hippocampus (Supplementary Tables 6 and 7) 
Overall, longitudinal changes in continuous BMI, WC or WTHR were not significantly 
associated with lower hippocampal volumes (Supplementary Tables 8 to 10), however, 
   
compared to participants who were NS for BMI, WC or WTHR, those who remained OS 
(BMI: B = -62.33, SE = 16.76; WC: B = -145.68, SE = 16.97 and WTHR: B = -101.44, 
SE = 19.54) or were ON (BMI: B = -61.15, SE = 30.3; WC: B = -93.81, SE = 24.96 and 
WTHR: B = -69.95, SE = 26.22) had significantly lower hippocampal volumes across all 
three measures of fat mass (Table 2). Participants who were NO for WC or WTHR also 
had significantly lower hippocampal volumes than those who were NS (WC: B = -74.4, 
SE = 25.51 and WTHR: B = -62.12, SE = 22.52). However, participants who were NO 
for BMI had no significant difference in hippocampal volume compared to those who 
were NS. These results were consistent for the left and right hippocampus for WC 
(Supplementary Tables 11 and 12). Although, for WTHR, no significant differences were 
found in the left hippocampus for the NO group compared to NS group, whereas for 
BMI, no significant differences were found in the right hippocampus for the ON group 
compared to the NS group. 
Analyses were repeated separately for women and men (Supplementary Tables 13 and 
14). For men, OS (BMI: B = -92.17, SE = 26.55; WC: B = -206.02, SE = 25.69 and 
WTHR: B = -114.98, SE = 29.08) and ON (BMI: B = -97.79, SE = 45.76; WC: B = -
91.18, SE = 34.5 and WTHR: B = -96.29, SE = 40.49) groups were consistently 
associated with lower hippocampal volumes compared with NS across all measures of fat 
mass. However, no significant differences in hippocampal volumes were consistently 
found between the NO and NS groups. For women, OS groups had consistently lower 
hippocampal volumes than NS across all measures of fat mass (BMI: B = -45.4, SE = 
21.52; WC: B = -101, SE = 22.49 and WTHR:  B = -71.13, SE = 28.66). For WC and 
   
WTHR, the NO group had lower hippocampal volumes than the NS group (WC: B = -
84.02, SE = 32.43 and WTHR:  B = -103.78, SE = 28.43), however, these differences 
were not found for BMI. ON participants had significantly lower hippocampal volumes 
compared to the NS group for WC (B = -113.2, SE = 36.52), however, this difference 
was not observed for WTHR or BMI.  
For each individual subgroup (i.e. NS, NO, OS, ON), annual change in BMI, WC or 
WTHR had no significant association with hippocampal volume (Supplementary Table 
15). This was consistently observed between women and men (Supplementary Tables 16 
and 17) and in analyses of the left and right hippocampus (Supplementary Tables 18 and 
19).  
As seen in Table 3, WC was most correlated with visceral fat (r = 0.83), compared to 
WTHR (r = 0.73) and BMI (r = 0.69). However, BMI was most correlated with total 




This study aimed to investigate the association between fat mass (i.e. BMI, WC and 
WTHR) and longitudinal changes in fat mass with hippocampal volumes in middle to 
   
early-old aged women and men. To better understand these relationships, the current 
study also aimed to determine whether observed associations differed between measures 
of fat mass and to identify which measure(s) of fat mass were most strongly associated 
with total body fat and visceral fat, as indicated by DEXA. The key findings were that (1) 
WC was most strongly correlated with visceral fat (r = 0.83), compared to WTHR (r = 
0.73) and BMI (r = 0.69), (2) individuals with chronic overweight/obesity had 
significantly lower hippocampal volumes (specifically, WC: 1.13%; WTHR: 0.79% and 
BMI: 0.49% smaller after adjusting for all covariates) when compared with those who 
maintained a normal level of fat mass (i.e. WC: < 80 cm in women and < 94 cm in men; 
WTHR: < 0.85 in women and < 0.90 in men and BMI: < 25 kg/m2 in women and men) at 
baseline and follow up (average follow up = 7.66 years) and (3) individuals who were 
within a normal range of fat mass at follow up assessment, yet were previously classified 
as having overweight/obesity at baseline had lower hippocampal volumes than those who 
remained normal stable (specifically, WC: 0.73%; WTHR: 0.55% and BMI: 0.48% 
smaller after adjusting for all covariates). The current findings emphasise the importance 
of maintaining normal weight for neurological health and also suggest that the 
detrimental effects of overweight/obesity may extend beyond the duration of 
overweight/obesity itself. 
Overweight/obesity is a complex condition which has multifactorial components 
(including genetic, environmental and socioeconomic factors) that underlie its aetiology. 
The current findings further highlight the complexity of overweight/obesity by 
emphasising the long term impact the condition may have on the neurological health of 
   
individuals. There are a number of possible biological mechanisms, which may explain 
the consistent finding that those who were OS or ON had lower hippocampal volumes 
than those who were NS, across all measures of fat mass. For example, previous studies 
have demonstrated that the accumulation of fat tissue, particularly visceral fat, is closely 
linked with elevated levels of pro-inflammatory cytokines (19-21), which have been 
associated with smaller hippocampal volumes (22). This is of particular importance as the 
current results revealed that (1) WC was most strongly associated with visceral fat and 
(2) the largest effect was consistently found for WC, as those who were OS and ON had 
1.13% and 0.73% smaller hippocampal volumes than NS for WC, respectively, compared 
with WTHR (OS: 0.79% and ON: 0.55% smaller hippocampus than NS) and BMI (OS: 
0.49% and ON: 0.48% smaller hippocampus than NS). Notably, no statistical differences 
between NS and NO groups were found for BMI, which was lowly correlated with 
visceral fat levels compared to WC but was most highly correlated with total body fat, 
yet, for both WC and WTHR the NO group had significantly lower hippocampal volumes 
than NS (0.58% and 0.49 % smaller respectively).  
Taken together, the current findings seem to suggest that an accumulated burden of 
pathology may have developed in those that were OS, ON and NO, perhaps as a result of 
chronic, low grade systemic inflammation that persists, commonly in individuals with 
overweight/obesity (due to an accumulation of visceral fat tissue), or other pathological 
mechanisms, resulting in lower hippocampal volumes compared to those who maintained 
a normal level of fat mass. This is consistent with the literature which has shown that 
chronic obesity is associated with a cascade of potentially harmful physiological 
   
processes (including oxidative stress, inflammation and insulin resistance) which are 
implicated in the deterioration of metabolic homeostasis (31), and has been linked with 
accelerated neurodegeneration (32). Furthermore, previous research has demonstrated 
that individuals who gained weight, lost weight or remained obese had an increased risk 
of mortality compared with those who maintained normal amounts of body fat (33). 
Therefore, these results appear to indicate that it is the chronicity of overweight/obesity 
which is associated with lower hippocampal volumes. However, an alternative 
explanation is that, for reasons not well understood, those who were ON or OS had lower 
hippocampal volumes at baseline. Whilst possible, this explanation is less likely given the 
substantial amount of evidence in the literature that has demonstrated the link between 
obesity and neurodegeneration (4, 34, 35), which also aligns with experimental data in 
animals showing that obesity in mice can lead to decreased neurogenesis and accelerated 
neurodegeneration, resulting in dementia pathology (36, 37). Nevertheless, it cannot be 
completely discounted that factors, such as sampling bias, may be present and future 
research should investigate this further. 
The use of BMI, WC and WTHR enabled the comparison of results across three 
commonly used clinical measures/indices of fat mass. Whilst more precise technology for 
measuring fat mass exists, such as dual-energy x-ray absorptiometry (DEXA) and 
magnetic resonance imaging (MRI) (38), these tools require relatively large investments 
of time, money and resources, compared to BMI, WC and WTHR. Furthermore, 
longitudinal measures of fat mass using DEXA or MRI are currently not available in the 
UK Biobank dataset. As a result, an important question raised by these findings is which 
   
clinical measure (i.e. BMI, WC or WTHR) best represents the association between fat 
mass and the hippocampus and may therefore be a better predictor of future 
neurodegeneration. Firstly, as previously noted, correlation analysis indicated that WC 
was most strongly associated with visceral fat (r = 0.83), compared to WTHR (r = 0.73) 
and BMI (r = 0.69). This may provide a theoretical rationale for its use as a clinical 
measure to assess the association between fat mass and the hippocampus. Furthermore, 
subgroup analysis in women revealed statistically significant differences between NO, 
OS, ON groups and those who were NS for WC, however, these differences were not 
consistently found for WTHR and BMI (Supplementary Table 13). Several possible 
reasons may account for these findings. For example, previous research has demonstrated 
that women tend to accumulate central fat (specifically visceral fat), during midlife (39), 
which may explain the observed associations, given that WC was most strongly 
correlated with visceral fat, which has been previously linked to neurodegeneration 
through the elevation of pro-inflammatory cytokines (22). Another possibility is that the 
individuals who were in each fat mass group (i.e. NS, NO, OS and ON) varied to a 
certain degree between measures (i.e. BMI, WC and WTHR) due to the differences with 
the standardised cutoff points used for categorisation. Therefore, the observed differences 
in results may reflect the sensitivity of the fat mass thresholds for each category (i.e. NS, 
NO, OS and ON) to better capture individuals who had healthier hippocampal volumes 
than others. To assess this, post-hoc analysis was conducted whereby a fifth group was 
established, which included individuals (n = 3998) who were consistently normal stable 
for all of BMI, WC and WTHR (henceforth called consistently normal stable i.e. CNS). 
   
Interestingly, for WC, no difference was found between those who were NS or CNS. 
Furthermore, the magnitude and significance of effects remained consistent between NS 
and NO, OS and ON groups with and without the inclusion of a CNS group 
(Supplementary Table 20). Alternatively, for WTHR and BMI the CNS group had 
significantly larger hippocampal volumes than those who were NS. Furthermore, the 
differences between ON and OS groups with NS for BMI were no longer detected once 
the CNS group was included. A similar result was observed for the ON and NO groups 
for WTHR. Therefore the CNS group was likely capturing the individuals with larger 
hippocampal volumes for BMI and WTHR, but not WC. This may be because BMI and 
WTHR measures reflect body size and on average head size, which is itself associated 
with hippocampal volume. These findings seem to further demonstrate the robustness and 
sensitivity of WC for assessing the relationship between visceral fat and hippocampal 
volume. Taken together, these results align with and extend upon previous studies, which 
have noted that WC is a more sensitive indicator for determining the adverse effects of 
overweight and obesity on brain health than BMI, particularly in females (40). 
 
Strengths and limitations 
Key strengths of the current study include (1), the large cohort of middle to early-old 
aged adults (specifically 20395 individuals) that included both men and women, (2) the 
use of longitudinal changes in fat mass and (3), the use of multiple commonly used 
clinical measures/indices of fat mass (including BMI, WC and WTHR) to address the 
   
questions of interest. Furthermore, due to the large sample size, a large number of 
relevant covariates could be adjusted for (including age, sex, follow up period, 
educational attainment, vascular/heart problems i.e. heart attack, angina or hypertension, 
diabetes, physical activity, smoking and alcohol intake), which ensured that observed 
associations were unlikely driven by common comorbid conditions that are often 
associated with obesity, such as diabetes, hypertension and physical activity levels. 
Notably, previous studies that have examined longitudinal changes in fat mass with 
hippocampal volumes in middle to early aged adults have been limited by sample size 
(12, 16, 17). Two of the three studies used BMI as their only measure of fat mass (16, 
17), one of which, focused on a sample consisting only of men (16), whereas the other 
used self-reported BMI (12) and the third estimated BMI and WC in participants at age 
50 (17). Given this, the current study is unique in its ability to directly measure, assess 
and discuss the temporal association between longitudinal changes in BMI, WC and 
WTHR, with the hippocampus, within a large cohort of both men and women. 
Furthermore, our analyses included normalised hippocampal volumes and had a low 
percentage of missingness for covariates (Table 1), which may help explain discrepancies 
with previous cross-sectional findings (18). 
A limitation of the current study is that imaging data was only available at one timepoint. 
Therefore, it is difficult to determine whether other age related factors could be 
responsible for the observed differences or, as previously discussed, whether these 
differences were already present a baseline. Furthermore, clear standardised thresholds 
for WC and WTHR that separate overweight and obese groups do not currently exist. 
   
This limited the ability to identify possible differences that may exist between overweight 
and obese participants for WC and WTHR. Additionally, of the 9.2 million individuals 
invited to enter the UK Biobank cohort, only 5.5% participated in the baseline assessment 
and were more likely to have a favourable health profile than the general population (i.e. 
less likely to be obese, smoke, consume alcohol daily and have fewer self-reported health 
conditions) (41). As a result, these findings may not be completely representative of the 
broader population and require replication in other datasets. Our study was limited to the 
association between changes in fat mass and the brain, however, future studies would 
benefit from investigating whether the observed results translate to differences in 
cognitive performance, particularly in domains related to the hippocampus, such as 
learning and memory.  
CONCLUSION 
The current findings emphasise the importance of maintaining normal weight for 
neurological health and also suggest that the detrimental effects of overweight/obesity 
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Figure 1 Fat mass change over follow up for each group. Abbreviations: NS, Normal 
stable; NO, Normal to overweight/obese; OS, Overweight/obese stable; ON, 
Overweight/obese to normal. 
Figure 2 Timeline of UK Biobank study. Abbreviations: BMI, Body Mass Index; WC, 
Waist Circumference; WTHR,  Waist to Hip Ratio; SD, Standard Deviation. 
  
   
 
Table 1 Demographic and health characteristics 
Characteristics/Measures  
Sample size; N 20395 
Age, years; mean, (SD) 54.86 (7.48) 
Follow up period, years; mean (SD) 7.66 (1.42) 
Female; N (%) 10658 (52.26) 
Body Mass Index, kg m -2; mean (SD) 26.67 (4.16) 
Waist Circumference, cm; mean (SD) 88.12 (12.44) 
Waist to Hip Ratio; mean (SD) 0.86 (0.087) 
Education college/degree; N (%) 9491 (46.54) 
Hypertension; N (%) 4240 (20.79) 
Diabetes; N (%) 540 (2.65) 
Ever smoker; N (%) 11623 (56.99) 
Total hippocampal volume, mm3; mean (SD) 7709.73 (867.92)  
Abbreviations: N, number; SD, standard deviation. 
Note: There were 109 (0.53%) missing for education, 147 
(0.72%) missing for hypertension, 4 (0.02%) missing for 





   
 
Table 2 Longitudinal categorical analysis results for total hippocampus 
Measure Predictors Estimate SE 95% CI P value R2 
BMI Normal to overweight/obese 
(NO) 
-45.94 32.24 -109.14 – 
17.25 
0.154 0.155 
 Overweight/obese stable (OS) -62.33 16.76 -95.17 – -
29.48 
<0.001  
 Overweight/obese to normal 
(ON) 
-61.15 30.30 -120.55 – -
1.76 
0.044  
WC Normal to overweight/obese 
(NO) 
-74.40 25.51 -124.40 – -
24.41 
0.004 0.157 
 Overweight/obese stable (OS) -145.68 16.97 -178.95 – -
112.41 
<0.001  
 Overweight/obese to normal 
(ON) 
-93.81 24.96 -142.73 – -
44.89 
<0.001  
WTHR Normal to overweight/obese 
(NO) 
-62.12 22.52 -106.27 – -
17.98 
0.006 0.155 
 Overweight/obese stable (OS) -101.44 19.54 -139.75 – -
63.13 
<0.001  
 Overweight/obese to normal 
(ON) 
-69.95 26.22 -121.35 – -
18.56 
0.008  
Abbreviations: SE, standard error; CI, confidence interval; BMI, Body Mass Index; WC, Waist 
Circumference; WTHR, Waist to Hip Ratio.                                                                                
Note: Model is adjusted for age, sex, follow up (years), education, vascular/heart problems, 
diabetes, physical activity, smoking and alcohol use. All estimates are unstandardised for the 
hippocampus i.e. mm3. 
 
  
   
 
Table 3 Simple Pearson correlation analysis results for between WC, WTHR, BMI and DEXA  
 TBF  95% CI P value VF 95% CI P value 
BMI 0.897 0.891 – 0.903 <0.001 0.688 0.672 – 0.703 <0.001 
WC 0.719 0.706 – 0.734 <0.001 0.827 0.817 – 0.836 <0.001 
WTHR 0.291 0.264 – 0.318 <0.001 0.728 0.714 – 0.742 <0.001 
Abbreviations: CI, confidence interval; BMI, Body Mass Index; WC, Waist Circumference; 
WTHR, Waist to Hip Ratio; VF, Visceral Fat; TBF, Total Body Fat; DEXA, Dual-Energy X-ray 
Absorptiometry 
Note: TBF and VF were measured for 4482 and 4431 participants, respectively, using DEXA. 
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